Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology
Authors:
- Kao-Jung ChangKCKao-Jung Chang
- Hsin-Yu WuHWHsin-Yu Wu
- Aliaksandr A. YarmishynAYAliaksandr A. Yarmishyn
- Cheng-Yi LiCLCheng-Yi Li
- Yu-Jer HsiaoYHYu-Jer Hsiao
- Yi-Chun ChiYCYi-Chun Chi
- Tzu-Chen LoTLTzu-Chen Lo
- He-Jhen DaiHDHe-Jhen Dai
- Yi-Chiang YangYYYi-Chiang Yang
- Ding-Hao LiuDLDing-Hao Liu
- De-Kuang HwangDHDe-Kuang Hwang
- Shih-Jen ChenSCShih-Jen Chen
Open Access
- 26 August 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (17) , 9707
Abstract
Cerebral visual impairments (CVIs) is an umbrella term that categorizes miscellaneous visual defects with parallel genetic brain disorders. While the manifestations of CVIs are diverse and ambiguous, molecular diagnostics stand out as a powerful approach for understanding pathomechanisms in CVIs. Nevertheless, the characterization of CVI disease cohorts has been fragmented and lacks integration. By revisiting the genome-wide and phenome-wide association studies (GWAS and PheWAS), we clustered a handful of renowned CVIs into five ontology groups, namely ciliopathies (Joubert syndrome, Bardet–Biedl syndrome, Alstrom syndrome), demyelination diseases (multiple sclerosis, Alexander disease, Pelizaeus–Merzbacher disease), transcriptional deregulation diseases (Mowat–Wilson disease, Pitt–Hopkins disease, Rett syndrome, Cockayne syndrome, X-linked alpha-thalassaemia mental retardation), compromised peroxisome disorders (Zellweger spectrum disorder, Refsum disease), and channelopathies (neuromyelitis optica spectrum disorder), and reviewed several mutation hotspots currently found to be associated with the CVIs. Moreover, we discussed the common manifestations in the brain and the eye, and collated animal study findings to discuss plausible gene editing strategies for future CVI correction.Keywords
Funding Information
- Taipei Veterans General Hospital (V111C-189, V111C-085, MOST 108-2314-B-010-042-MY3, MOST 111-2314-B-A49-057-MY3)
- Ministry of Science and Technology, Israel (V111C-189, V111C-085, MOST 108-2314-B-010-042-MY3, MOST 111-2314-B-A49-057-MY3)
This publication has 517 references indexed in Scilit:
- Coil‐to‐helix transitions in intrinsically disordered methyl CpG binding protein 2 and its isolated domainsProtein Science, 2012
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- Joubert Syndrome 2 (JBTS2) in Ashkenazi Jews Is Associated with a TMEM216 MutationThe American Journal of Human Genetics, 2010
- Clinical and molecular features of Joubert syndrome and related disordersAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2009
- OFD1 Is Mutated in X-Linked Joubert Syndrome and Interacts with LCA5-Encoded LebercilinThe American Journal of Human Genetics, 2009
- CC2D2Amutations in Meckel and Joubert syndromes indicate a genotype-phenotype correlationHuman Mutation, 2009
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- MKS3/TMEM67mutations are a major cause of COACH Syndrome, a Joubert Syndrome related disorder with liver involvementHuman Mutation, 2008
- Mutations in the chromatin-associated protein ATRXHuman Mutation, 2008
- CC2D2A, Encoding A Coiled-Coil and C2 Domain Protein, Causes Autosomal-Recessive Mental Retardation with Retinitis PigmentosaThe American Journal of Human Genetics, 2008